|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_ForwardLookingEvaluationsAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
Within the scope of Article 10 of the Capital Markets Board's (CMB) Communiqué on Material Events No. II-15.1, the consolidated revenue expectation for 2024 was stated as EUR 29mn and EBITDA as EUR 27mn in the investor presentation, which was last shared on May 21, 2024, including our Company's current operational and financial data and future projections. As of December 31, 2024 consolidated financial statements, revenue was approximately EUR 33mn, which was above the guidance, and EBITDA was approximately EUR 29mn, which was also above the guidance.
In addition, within the scope of the Announcements made in the CMB Bulletin No. 2024/14 pursuant to the CMB Decision No. 14/382 dated 07.03.2024 and in the CMB Bulletin No. 2024/38 pursuant to the CMB Decision No. 42/1263 dated 08.08.2024, the impact of TAS 29 inflation accounting, which was started to be applied as of the end of 2023, on the consolidated financial statements of our Company as of December 31, 2024 is presented for the information of our investors as of the selected financial statement items stated in the appendix.
The English translation of this disclosure is attached hereto, and in case of any discrepancy in the texts of the disclosure, the Turkish disclosure will be accepted as the basis.
|
||||||||